Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Genital Epstein Barr Virus is associated with higher prevalence and persistence of anal human papillomavirus in HIV-infected men on antiretroviral therapy

Fig. 1

a Prevalence of detectable anal HR-HPV mRNA at every study visit (baseline and weeks 12, 24, 36, and 48) divided by groups (EBV shedders versus EBV non-shedders). Black bars show EBV shedders; gray bars show EBV non-shedders. **P < 0.001. b Kaplan Meier analysis of time to first negative anal HR-HPV Results among participants with detectable HR-HPV mRNA at Baseline during 48 weeks of follow-up in subjects with detectable seminal EBV DNA (in black) and without detectable seminal EBV DNA (in gray) at baseline

Back to article page